TGF beta (type II)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf97/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf97/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf95/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf95/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf94/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf94/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf93/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf93/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf92/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf92/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf91/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf91/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf90/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf90/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf8f/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf8f/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf8e/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf8e/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf8d/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf8d/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf8c/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf8c/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf8b/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf8b/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf8a/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf8a/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf89/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf89/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf88/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf88/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf87/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf87/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf86/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf86/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf85/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf85/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf84/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf84/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf83/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf83/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf82/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf82/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf81/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf81/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf80/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf80/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf7f/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf7f/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf7e/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf7e/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf7d/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf7d/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf7c/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf7c/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf7b/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf7b/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf7a/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf7a/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf79/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf79/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf78/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf78/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf77/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf77/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf76/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf76/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf75/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf75/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf74/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf74/tgf-beta-type-ii.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc27e30380d0028b9bf73/tgf-beta-type-ii.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc27e30380d0028b9bf73/tgf-beta-type-ii.png"}]
Keywords
serine kinase receptor,threonine kinase receptor,type I,type II,type 1,type 2,TGF beta,transforming growth factor beta, TGF β,type II,type 2